2m 2m 2m 2m 2m 2m 2m
PULMONX (LUNG)
NASDAQ
$1.53-$0.09 (-5.28%)
Price as of Jun 03, 2026 4:10 PM EDT- $69.7MMarket Cap
- -49.37%1-Year Change
- Medical DevicesIndustry
PULMONX (LUNG)
$1.53-$0.09 (-5.28%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 90.5M +8.01% | 83.8M +22.01% | 68.7M +27.98% | 53.7M +10.84% | |
Cost of Revenue | 23.4M +7.21% | 21.8M +21.56% | 17.9M +29.91% | 13.8M +7.91% | |
Gross Profit | 67.1M +8.29% | 62.0M +22.16% | 50.8M +27.31% | 39.9M +11.89% | |
Sales and Marketing Expense | 101.3M -0.81% | 102.1M +7.96% | 94.6M +13.84% | 83.1M +18.94% | |
Research and Development Expense | -19.5M +10.93% | -17.6M -2.82% | -18.1M +17.43% | -15.4M +17.87% | |
Depreciation and Amortization Expense | 1.1M -29.40% | 1.5M -3.55% | 1.5M +2.31% | 1.5M +74.51% | |
Total Operating Expenses | 120.8M +0.92% | 119.7M +6.23% | 112.7M +14.40% | 98.5M +18.77% | |
Operating Profit | -53.7M -7.00% | -57.7M -6.83% | -61.9M +5.62% | -58.6M +23.96% | |
Interest Income | 2.7M -47.62% | 5.1M -9.11% | 5.6M +264.16% | 1.5M +282.25% | |
Interest Expense | N/A N/A | N/A N/A | -3.2M +203.19% | -1.1M +28.59% | |
Interest Income and Expense and Net | 2.7M -47.62% | 5.1M +116.65% | 2.3M +404.54% | 463,000 +207.93% | |
Total Nonoperating Income and Expense | 790,000 +208.59% | 256,000 +138.04% | -673,000 +69.95% | -396,000 -32.31% | |
Income before Taxes | -53.4M -4.50% | -55.9M -7.26% | -60.3M +2.91% | -58.6M +21.22% | |
Income Taxes | 626,000 +25.20% | 500,000 -12.43% | 571,000 +61.76% | 353,000 +2.92% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -54.0M -4.24% | -56.4M -7.31% | -60.8M +3.26% | -58.9M +21.09% | |
Net Income from Continuing Operations Applicable to Common | -53.4M -4.50% | -55.9M -7.26% | -60.3M +2.91% | -58.6M +21.22% | |
Basic EPS and Net Income | -1.33 -7.64% | -1.44 -10.00% | -1.60 +0.63% | -1.59 +17.78% | |
Diluted EPS and Net Income | -1.33 -7.64% | -1.44 -10.00% | -1.60 +0.63% | -1.59 +17.78% | |
Basic Weighted Average Shares | 40.7M +4.03% | 39.1M +2.99% | 38.0M +2.37% | 37.1M +2.68% | |
Diluted Weighted Average Shares | 40.7M +4.03% | 39.1M +2.99% | 38.0M +2.37% | 37.1M +2.68% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 69.8M -1.63% | 70.9M -15.13% | 83.5M -17.88% | 101.7M -31.48% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 39.4M +24.84% | |
Cash and Cash Equivalents and Short-Term Investments | 69.8M -1.63% | 70.9M -15.13% | 83.5M -40.80% | 141.1M -21.61% | |
Total Current Assets | 101.7M -25.37% | 136.2M -9.42% | 150.4M -10.97% | 169.0M -18.77% | |
Accumulated Depreciation | 6.7M +16.18% | 5.7M +17.90% | 4.9M +36.53% | 3.6M +58.54% | |
Property and Plant and Equipment and Net | 2.2M -23.63% | 2.9M -27.83% | 4.0M -14.19% | 4.7M -2.49% | |
Total Long-Term Assets | 1.4M +25.18% | 1.1M +92.22% | 591,000 +11.72% | 529,000 -27.63% | |
Total Assets | 129.3M -20.61% | 162.8M -8.40% | 177.8M -8.21% | 193.7M -17.65% | |
Income Taxes Payable | 332,000 +144.12% | 136,000 -34.30% | 207,000 +83.19% | 113,000 -38.59% | |
Total Short-Term Debt | 106,000 -96.66% | 3.2M +47.38% | 2.2M +2,294.44% | 90,000 -1.10% | |
Total Current Liabilities | 20.1M -17.92% | 24.4M +5.53% | 23.2M +25.23% | 18.5M +5.37% | |
Total Long-Term Debt | 37.0M +8.78% | 34.0M -3.10% | 35.1M N/A | 0 -100.00% | |
Total Long-Term Liabilities | 55.2M +4.74% | 52.7M +44.66% | 36.4M +802.23% | 4.0M -41.64% | |
Total Liabilities | 75.2M -2.42% | 77.0M +29.55% | 59.5M +49.91% | 39.7M -5.40% | |
Retained Earnings | -521.6M +11.55% | -467.6M +13.72% | -411.2M +17.37% | -350.3M +20.22% | |
Total Stockholders Equity | 54.1M -36.93% | 85.8M -27.47% | 118.3M -23.18% | 154.0M -20.30% | |
Total Shares Outstanding | 41.7M +4.74% | 39.8M +3.30% | 38.5M +2.56% | 37.6M +1.69% | |
Cash Flow | |||||
Cash from Operating Activities | -32.4M +2.66% | -31.5M -16.15% | -37.6M -16.58% | -45.1M +8.93% | |
Capital Expenditures | 452,000 -68.76% | 1.4M +79.31% | 807,000 -38.77% | 1.3M -64.10% | |
Cash from Investing Activities | 30.5M +74.42% | 17.5M +970.75% | -2.0M -52.50% | -4.2M -90.87% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 833,000 -38.88% | 1.4M -93.63% | 21.4M +784.66% | 2.4M -45.71% | |
Financials Ratio | |||||
Gross Margin | 74.19% +0.26% | 74.00% +0.13% | 73.90% -0.52% | 74.29% +0.95% | |
Operating Margin | -59.30% -13.90% | -68.87% -23.64% | -90.19% -17.47% | -109.27% +11.84% | |
Return on Assets | -36.97% +11.65% | -33.11% +1.08% | -32.76% +19.21% | -27.48% +40.86% | |
Return on Equity | -77.19% +39.70% | -55.25% +23.65% | -44.68% +31.67% | -33.94% +46.24% | |
Revenue Growth | 8.01% -63.62% | 22.01% -21.34% | 27.98% +158.20% | 10.84% -77.38% | |
Current Ratio | 5.07 -9.08% | 5.58 -14.17% | 6.50 -28.90% | 9.14 -22.91% | |
Cash Ratio | 3.48 +19.85% | 2.90 -19.58% | 3.61 -34.42% | 5.50 -34.97% | |
Debt-to-Equity Ratio | 0.69 +58.20% | 0.43 +37.64% | 0.31 +52,366.67% | 0.0006 -84.21% | |
Debt-to-Assets Ratio | 0.29 +25.67% | 0.23 +8.97% | 0.21 +41,800.00% | 0.0005 -83.87% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow